ArticleFrontiers in immunology2022

Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway.

Alessandra D'Abramo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.